Ascent Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,121
Closed -$1.55M 181
2025
Q1
$1.55M Buy
3,121
+5
+0.2% +$2.71K 0.21% 98
2024
Q4
$1.62M Sell
3,116
-9
-0.3% -$4.95K 0.22% 82
2024
Q3
$1.93M Buy
3,125
+12
+0.4% +$7.1K 0.27% 76
2024
Q2
$1.72M Buy
3,113
+30
+1% +$17.2K 0.25% 81
2024
Q1
$1.73M Buy
+3,083
New +$1.73M 0.26% 76

Other funds holding TMO

Ascent Wealth Partners's TMO Position: Q2 2025 in Review

Ascent Wealth Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 3,121 shares — an estimated $1.55M sold.

Ascent Wealth Partners first reported a position in TMO in Q1 2024 and held it in 5 quarters. The position peaked at $1.93M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Ascent Wealth Partners reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Ascent Wealth Partners sold 3,121 Thermo Fisher Scientific shares in Q2 2025, an estimated $1.55M.
  • Ascent Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 5 quarters.
  • Ascent Wealth Partners's Thermo Fisher Scientific position peaked at $1.93M in Q3 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Ascent Wealth Partners's 13F filing for Q2 2025, filed 12 Aug 2025.